Mosaicism for trisomy 17-18 and trisomy 13-15 in man

Patterns of failure with increasing intensification of induction chemotherapy for acute myeloid leukaemia.

British journal of haematology·2001

Long-term survival of patients with acute myeloid leukemia: a third follow-up of the Fourth International Workshop on Chromosomes in Leukemia.

Cancer·1997

Prognostic value of cytogenetic abnormalities in previously untreated patients with non-Hodgkin's lymphoma.

Leukemia & lymphoma·1997

A randomized study of high-dose cytarabine in induction in acute myeloid leukemia.

Blood·1996

Application of interphase cytogenetics to monitor bone marrow transplants.

American journal of hematology·1995

New translocation t(2;13)(p12;q34) and rearrangement of the MLL gene in a childhood leukemia cell line.

Genes, chromosomes & cancer·1995

An operational perturbation proteomics-based virtual cell model.

Nature·2026

Integrated signatures define mutational processes in prostate cancer.

Nature·2026

Advancing conflict research and response through satellite-derived data.

Nature·2026

Imaging cellular activity across all organs reveals body-wide circuits.

Nature·2026

Neocortical long-range inhibition promotes cortical synchrony and sleep.

Nature·2026

TRI-611, a selective, brain-penetrant molecular glue degrader of ALK.

Nature·2026

Clinical Efficacy of High-Frequency Deep Repetitive Transcranial Magnetic Stimulation in the Treatment of Depression and the Predictive Role of Baseline Triglyceride Levels: A Randomized Sham-Controlled Trial.

Clinical EEG and neuroscience·2026

Mechanistic Basis and Therapeutic Potential of a Novel TXNIP Inhibitor in Diabetes Treatment.

Journal of medicinal chemistry·2026

Discovery of BRD9 PROTAC/IMiD Bifunctional Molecules as Potent Therapeutics for Hematologic Malignancies.

Journal of medicinal chemistry·2026

First line asciminib in chronic myeloid leukemia: a quest for the "Holy Grail" of tolerability.

Haematologica·2026

Successful treatment of systemic juvenile xanthogranuloma with an ABL2::GAB2 fusion using dasatinib after failure of conventional chemotherapy and MEK inhibition.

Haematologica·2026

Repurposing MK0873 as a non-covalent hTERT-Targeting compound: a proof of concept study.

Frontiers in aging·2026

Related Experiment Videos

Mosaicism for trisomy 17-18 and trisomy 13-15 in man

Related Concept Videos

Patterns of failure with increasing intensification of induction chemotherapy for acute myeloid leukaemia.

Long-term survival of patients with acute myeloid leukemia: a third follow-up of the Fourth International Workshop on Chromosomes in Leukemia.

Prognostic value of cytogenetic abnormalities in previously untreated patients with non-Hodgkin's lymphoma.

A randomized study of high-dose cytarabine in induction in acute myeloid leukemia.

Application of interphase cytogenetics to monitor bone marrow transplants.

New translocation t(2;13)(p12;q34) and rearrangement of the MLL gene in a childhood leukemia cell line.

An operational perturbation proteomics-based virtual cell model.

Integrated signatures define mutational processes in prostate cancer.

Advancing conflict research and response through satellite-derived data.

Imaging cellular activity across all organs reveals body-wide circuits.

Neocortical long-range inhibition promotes cortical synchrony and sleep.

TRI-611, a selective, brain-penetrant molecular glue degrader of ALK.

Clinical Efficacy of High-Frequency Deep Repetitive Transcranial Magnetic Stimulation in the Treatment of Depression and the Predictive Role of Baseline Triglyceride Levels: A Randomized Sham-Controlled Trial.

Mechanistic Basis and Therapeutic Potential of a Novel TXNIP Inhibitor in Diabetes Treatment.

Discovery of BRD9 PROTAC/IMiD Bifunctional Molecules as Potent Therapeutics for Hematologic Malignancies.

First line asciminib in chronic myeloid leukemia: a quest for the "Holy Grail" of tolerability.

Successful treatment of systemic juvenile xanthogranuloma with an ABL2::GAB2 fusion using dasatinib after failure of conventional chemotherapy and MEK inhibition.

Repurposing MK0873 as a non-covalent hTERT-Targeting compound: a proof of concept study.

Related Experiment Videos

Mosaicism for trisomy 17-18 and trisomy 13-15 in man

Related Concept Videos

Related Articles